Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            April 16, 2020
            Published by admin on April 16, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing (NGS) Based Antibiotic Susceptibility Testing (AST) in Multi-Center Study

            VIENNA, Austria and GAITHERSBURG, Md., April 16, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics […]
            Do you like it?0
            Read more
            April 1, 2020
            Published by admin on April 1, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis and OpGen Complete Business Combination

            Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 01, 2020, 10:00 pm CET – Curetis N.V. (in liquidation) (the “Company”) today announced that the business combination between […]
            Do you like it?0
            Read more
            March 30, 2020
            Published by admin on March 30, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Shareholder Approval for Business Combination with Curetis

            GAITHERSBURG, Md., March 30, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to […]
            Do you like it?0
            Read more
            March 16, 2020
            Published by admin on March 16, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

            Holzgerlingen, Germany, March 16, 2020, 08:00 am CET – Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, […]
            Do you like it?0
            Read more
            March 10, 2020
            Published by admin on March 10, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis N.V. Reports Results of the Extraordinary General Meeting

            Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, March 10, 2020, 14:15 pm CET – Curetis N.V. (the “Company” and together with its subsidiaries […]
            Do you like it?0
            Read more
            March 4, 2020
            Published by admin on March 4, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Epigenomics Request Triggers Centers for Medicare and Medicaid Services (CMS) Plan To Cover Colorectal Cancer Blood-Based Biomarker Tests

            03 Mar 2020 – MedTech Insights – The US Centers for Medicare and Medicaid Services is considering a national coverage determination for a blood-based biomarker screening […]
            Do you like it?0
            Read more
            March 2, 2020
            Published by admin on March 2, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Centers for Medicare & Medicaid Services (CMS) Open National Coverage Determination (NCD) Review Process for Epi proColon

            Berlin, 28.02.2020– Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) announces that the Centers for Medicare & Medicaid Services (CMS) have opened the National […]
            Do you like it?0
            Read more
            January 31, 2020
            Published by admin on January 31, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe

            Vienna, Austria, Holzgerlingen, Germany, and Shenzhen, China, January 30, 2020, 08:00 am CET – Ares Genetics GmbH, a Curetis Group company, and the Chinese genomics company […]
            Do you like it?0
            Read more
            January 14, 2020
            Published by admin on January 14, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Launches Recently FDA-cleared Unyvero Lower Respiratory Tract (LRT) Pneumonia Pathogen Panel for Bronchoalveolar Lavage (BAL) Specimens in the U.S.

            Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, January 14, 2020, 08:00 am CET — Curetis N.V. (the “Company” and, together with its subsidiaries, […]
            Do you like it?0
            Read more
            Prev page
            1234567891011121314
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕